格雷斯海姆是制药、生物技术和护肤品行业的全球合作伙伴，致力于为客户提供全球领先的创新系统和解决方案。集团提供完整的药品包装解决方案、给药系统和医疗装置产品组合，并能为医疗保健行业提供综合解决方案。公司产品范围包括用于治疗支持的数字解决方案、贴敷式注射器、预灌封注射器、注射笔、自助注射器和吸入器，以及西林瓶、安瓿瓶、固体塑料瓶、输液套装、滴眼剂瓶及糖浆瓶等产品组合。格雷斯海姆确保为患者提供安全的药物输送和可靠的给药方式。格雷斯海姆通过沿价值链为客户提供全面的服务，支持客户应对日益增长的可持续发展需求。集团在欧洲、美洲和亚洲共16个国家设有超过40个生产基地，其业务遍布全球，并在全球不同区域市场实现本地化生产。集团现拥有13,400余名员工，2023年实现营业收入约20亿欧元。德国格雷斯海姆集团(Gerresheimer AG)在法兰克福证券交易所上市，被纳入MDAX指数(ISIN：DE000A0LD6E6)。
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. The Group generated revenues of around €2bn in 2023 and currently employs around 13,400 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
产品编号
额定容量
满装容量
外径
高度
口径
闭合系统
形状
防儿童开启
防拆封
应用
区域
采购中心
